González Juanatey, C., Vázquez Rodríguez, T. R., Miranda Filloy, J. A., Testa Fernández, A., García Porrúa, C., & Sánchez-Andrade Fernández, A. (2012). Anti-TNF-alpha-adalimumab therapy is associated with persistent improvement of endothelial function without progression of carotid intima-media wall thickness in patients with rheumatoid arthritis refractory to conventional therapy.
Citación estilo ChicagoGonzález Juanatey, Carlos, Tomás Ramón Vázquez Rodríguez, José Alberto Miranda Filloy, Ana Testa Fernández, Carlos García Porrúa, y Amalia Sánchez-Andrade Fernández. Anti-TNF-alpha-adalimumab Therapy Is Associated With Persistent Improvement of Endothelial Function Without Progression of Carotid Intima-media Wall Thickness in Patients With Rheumatoid Arthritis Refractory to Conventional Therapy. 2012.
Cita MLAGonzález Juanatey, Carlos, et al. Anti-TNF-alpha-adalimumab Therapy Is Associated With Persistent Improvement of Endothelial Function Without Progression of Carotid Intima-media Wall Thickness in Patients With Rheumatoid Arthritis Refractory to Conventional Therapy. 2012.